Viewing Protocol Section

Viewing Protocol Section

Thank You for evaluating our software.

Clinical Trials

To give you an idea of how we make custom software. We have taken all of the Clinical Trials Information from our Federal Government(https://clinicaltrials.gov/).

The JSON File Structure of the files is as follows: Full Study -> Study => Sections => Modules. You are currently viewing a Protocol Section and its Modules.

We give the table structure here to give you an idea of what you are looking at. We put the explanation to the left and the data to the right.

A Protocol Section has the following Modules.

1. Identification Module

2. Status Module

3. Sponsor Collaborators Module

4. Oversight Module

5. Description Module

6. Conditions Module

7. Design Module

8. Arms Interventions Module

9. Outcomes Module

10. Eligibility Module

11. Contacts Locations Module

12. References Module

13. IPD Sharing Statement Module

Viewing Protocol Section


Ignite Creation Date: 2024-05-05 @ 10:01 AM
Last Modification Date: 2024-10-26 @ 9:02 AM
Study NCT ID: NCT00000903
Protocol Section: NCT00000903
Start Identification Module Data
Brief Title: Addition of Efavirenz or Nelfinavir to a LamivudineZidovudineIndinavir HIV Treatment Regimen
Official Title: A Phase III Randomized Controlled Trial of Efavirenz EFV or Nelfinavir NFV in Combination With Fixed-Dose Combination LamivudineZidovudine 3TCZDV and Indinavir IDV in HIV-Infected Subjects With Less Than or Equal to 200 CD4 Cellsmm3 or Greater Than or Equal to 80000 HIV RNA Copiesml in Plasma
Acronym: None
Organization: National Institute of Allergy and Infectious Diseases NIAID
Organization Class: NIH
Organization Study ID: ACTG 388
Secondary IDs
Secondary ID Type Domain Link
Substudy ACTG 746 Registry Identifier DAIDS ES None
11347 REGISTRY None None
Substudy ACTG 734 None None None
Substudy ACTG A5060s None None None
Substudy ACTG 732 None None None
Substudy ACTG 733 None None None
Substudy ACTG 735 None None None
Substudy ACTG 737 None None None
Start Status Module Data
Status Verified Date: 2012-05
Overall Status: COMPLETED
Study First Submit Date:
Study First Submit QC Date:
Last Update Submit Date:
Status:
Start Sponsor Collaborators Module Data
Investigator:
Lead Sponsor: National Institute of Allergy and Infectious Diseases NIAID
Lead Sponsor Class: NIH
Lead Sponsor: National Institute of Allergy and Infectious Diseases NIAID
Start Oversight Module Data
Description Module:
Study Last Update Post Date Type(Status Module):
Attachment: Upload